
Advanced Glycation End Products Are Associated With Inflammation and Endothelial Dysfunction in HIV
Author(s) -
Vanessa El Kamari,
Alicia Thomas,
Lingpeng Shan,
Abdus Sattar,
Vincent M. Monnier,
Scott K. Howell,
Paul J. Beisswenger,
Grace A. McComsey
Publication year - 2019
Publication title -
journal of acquired immune deficiency syndromes
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.162
H-Index - 157
eISSN - 1944-7884
pISSN - 1525-4135
DOI - 10.1097/qai.0000000000002030
Subject(s) - medicine , endothelial dysfunction , inflammation , immunology , human immunodeficiency virus (hiv) , young adult , advanced glycation end product , glycation , endothelial activation , physiology , diabetes mellitus , endocrinology
To compare levels of advanced glycation end products (AGEs) between HIV-infected patients and uninfected controls and assess the relationship between AGEs, HIV, inflammation, and endothelial dysfunction.